Innovation Pharmaceuticals Inc (IPIX)

[loanranger]

There has been no showing provided that he actually made such a statement. But there is this, from the linked PR:

"The initial payment will help cover substantially the costs of our upcoming clinical study of oral-dosed Brilacidin currently being developed for treating Ulcerative Colitis (UC)."
http://www.ipharminc.com/press-release/2019/7/29/innovation-pharmaceuticals-provides-corporate-update-highlighting-clinical-pipeline-progress-and-business-development-activities


IF there is to be a "very small, very brief Phase 1" as you say, how much would you expect that very small, very brief trial to cost? The Company provides a timing estimate ("to commence later this year or early thereafter") but I didn't see their quantification of small and brief. Did you?